Equity Analysis /
United States of America

US : Antares Pharma, Inc. - ATRS | Weekly Rx Metrics: Slight Downtick in XYOSTED TRxs, Epi Franchise Largely Flat

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    28 March 2022
    Published by